Tazawa J, Sakai Y, Yamane M, Kakinuma S, Maeda M, Suzuki K, Miyasaka Y, Nagayama K, Kusano F, Sato C
Department of Internal Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Tuchiura City, Japan.
J Clin Gastroenterol. 2000 Oct;31(3):262-7. doi: 10.1097/00004836-200010000-00019.
Two patients with hepatocellular carcinoma (HCC) were treated with transjugular intrahepatic portosystemic stent-shunt (TIPS) and followed for 22 and 58 months thereafter. HCC was well controlled by transcatheter arterial chemoembolization. Hepatic failure or metastasis, especially in the lung, was not observed in the long-term observation. TIPS seems to be useful even in patients with HCC, provided HCC is controlled.
两名肝细胞癌(HCC)患者接受了经颈静脉肝内门体分流术(TIPS)治疗,之后分别随访了22个月和58个月。HCC通过经动脉化疗栓塞得到了良好控制。在长期观察中未观察到肝衰竭或转移,尤其是肺转移。如果HCC得到控制,TIPS似乎对HCC患者也有用。